Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.
Shimazaki
C
C
Second Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Inaba
T
T
Murakami
S
S
Fujita
N
N
Nakagawa
M
M
Gulati
S C
SC
Fried
J
J
Clarkson
B D
BD
Wisniewolski
R
R
Wang
C Y
CY
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000096:biosynthesis; D001853:Bone Marrow / Q000187:drug effects / Q000276:immunology; D001854:Bone Marrow Cells; D003114:Colony-Forming Units Assay; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000031:analogs & derivatives / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D008280:Magnetics; D008863:Microspheres; D009101:Multiple Myeloma / Q000628:therapy*; D014407:Tumor Cells, Cultured; D014410:Tumor Stem Cell Assay
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D005047:Etoposide; D003520:Cyclophosphamide; C011272:perfosfamide